首都医药
首都醫藥
수도의약
CAPITAL MEDICINE
2013年
22期
51-52
,共2页
氟比洛芬酯%病人自控静脉镇痛%舒芬太尼
氟比洛芬酯%病人自控靜脈鎮痛%舒芬太尼
불비락분지%병인자공정맥진통%서분태니
Flurbiprofen%Patient-controlled Intravenous Analgesia%Sufentanil
目的:本研究拟将氟比洛芬酯应用于术后病人自控静脉镇痛,以观察其镇痛效果。方法将60例全身麻醉下接受妇科开腹手术的女性患者随机分为两组,在术后开始应用不同配方的镇痛泵,分别为舒芬太尼组(S组)和舒芬太尼+氟比洛芬酯组(SF组)。于术后1h、4h、8h、24h和48h随访患者,记录两组镇痛效果,累计镇痛药消耗量及不良反应。结果两组病人的人口统计学无显著差异。术后各个时间点的静息和活动VAS评分均没有显著差异。SF组的舒芬太尼消耗量从术后4h开始明显少于S组。恶心呕吐发生率没有统计学差异。结论镇痛泵中加入氟比洛芬酯可以使术后舒芬太尼的用量减少,而疼痛评分和副作用发生率没有变化。
目的:本研究擬將氟比洛芬酯應用于術後病人自控靜脈鎮痛,以觀察其鎮痛效果。方法將60例全身痳醉下接受婦科開腹手術的女性患者隨機分為兩組,在術後開始應用不同配方的鎮痛泵,分彆為舒芬太尼組(S組)和舒芬太尼+氟比洛芬酯組(SF組)。于術後1h、4h、8h、24h和48h隨訪患者,記錄兩組鎮痛效果,纍計鎮痛藥消耗量及不良反應。結果兩組病人的人口統計學無顯著差異。術後各箇時間點的靜息和活動VAS評分均沒有顯著差異。SF組的舒芬太尼消耗量從術後4h開始明顯少于S組。噁心嘔吐髮生率沒有統計學差異。結論鎮痛泵中加入氟比洛芬酯可以使術後舒芬太尼的用量減少,而疼痛評分和副作用髮生率沒有變化。
목적:본연구의장불비락분지응용우술후병인자공정맥진통,이관찰기진통효과。방법장60례전신마취하접수부과개복수술적녀성환자수궤분위량조,재술후개시응용불동배방적진통빙,분별위서분태니조(S조)화서분태니+불비락분지조(SF조)。우술후1h、4h、8h、24h화48h수방환자,기록량조진통효과,루계진통약소모량급불량반응。결과량조병인적인구통계학무현저차이。술후각개시간점적정식화활동VAS평분균몰유현저차이。SF조적서분태니소모량종술후4h개시명현소우S조。악심구토발생솔몰유통계학차이。결론진통빙중가입불비락분지가이사술후서분태니적용량감소,이동통평분화부작용발생솔몰유변화。
Objective This study is designed to observe the analgesic effect of flurbiprofen in postoperative patient-controlled intravenous analgesia.Methods 60 female patients scheduled for gynecologic abdominal surgery under general anesthesia were randomly assigned to either sufentanil group (S group) or sufentanil+flurbiprofen group (SF group) as postoperative patient-controlled intravenous analgesia.At 1h,4h,8h,24h and 48h postoperatively,patients were followed and analgesic effect,total analgesic consumption and adverse reactions were recorded.Results There were no significant differences regarding the demographic data.VAS scores at rest and activity were not significantly different.Sufentanil consumption of SF group from 4 hours was significantly less than S group.The incidence of nausea and vomiting was not statistically significant.Conclusion Analgesia added flurbiprofen can reduce the amount of postoperative sufentanil,and pain scores and incidence of side effects did not change.